Malegra DXT: Dual-Action Therapy for Erectile Dysfunction and Premature Ejaculation
| Product dosage: 130mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.77 | $53.22 (0%) | 🛒 Add to cart |
| 60 | $1.42 | $106.44 $85.35 (20%) | 🛒 Add to cart |
| 90 | $1.31 | $159.66 $117.48 (26%) | 🛒 Add to cart |
| 120 | $1.25 | $212.87 $149.61 (30%) | 🛒 Add to cart |
| 180 | $1.19 | $319.31 $214.88 (33%) | 🛒 Add to cart |
| 270 | $1.15
Best per pill | $478.97 $311.28 (35%) | 🛒 Add to cart |
Similar products
Malegra DXT is a clinically formulated, dual-action medication designed to address two of the most prevalent male sexual health concerns: erectile dysfunction (ED) and premature ejaculation (PE). Combining the proven efficacy of Sildenafil Citrate, a PDE5 inhibitor, with Dapoxetine, a selective serotonin reuptake inhibitor (SSRI), this treatment offers a comprehensive solution. It works by enhancing blood flow to the penile tissues to facilitate firm erections while simultaneously increasing serotonin levels in the central nervous system to improve ejaculatory control. This synergistic approach allows for a more confident and satisfying sexual experience, supported by rigorous pharmaceutical standards. It is prescribed for men diagnosed with both conditions, providing a streamlined therapeutic option.
Features
- Active Ingredients: Sildenafil Citrate (100mg) and Dapoxetine Hydrochloride (60mg)
- Dosage Form: Film-coated tablets for oral administration
- Mechanism of Action: Dual mechanism—PDE5 inhibition and serotonin reuptake inhibition
- Onset of Action: Typically within 30-60 minutes post-administration
- Duration of Effect: Sildenafil effects last up to 4-6 hours; Dapoxetine effects are acute and situational
- Manufacturing Standards: Produced in GMP-certified facilities ensuring purity and consistency
- Packaging: Blister packs for stability and portability
Benefits
- Achieves and sustains firmer erections suitable for sexual activity
- Significantly delays ejaculation, improving intravaginal ejaculatory latency time (IELT)
- Enhances overall sexual satisfaction and confidence for both partners
- Convenient single-tablet regimen reduces pill burden compared to separate medications
- Allows for spontaneity with a rapid onset of action
- Supported by clinical evidence for efficacy and safety in comorbid ED and PE
Common use
Malegra DXT is indicated for the treatment of adult men experiencing both erectile dysfunction and premature ejaculation. It is suitable for individuals who have been diagnosed with these concurrent conditions and seek a unified pharmacological approach. The medication is intended for use prior to anticipated sexual activity and is not recommended for daily dosing. It is commonly prescribed following a thorough medical evaluation to rule out contraindications and ensure appropriateness based on the patient’s health profile and concomitant medications.
Dosage and direction
The recommended dosage is one tablet taken orally with a full glass of water approximately 1 to 3 hours before anticipated sexual activity. It may be taken with or without food, though high-fat meals may delay the onset of action. The tablet should be swallowed whole and not crushed or chewed. Do not exceed one dose within a 24-hour period. Dosage adjustments may be necessary based on individual tolerance, efficacy, and hepatic or renal function, but any changes must be supervised by a healthcare provider.
Precautions
- Prior to use, disclose full medical history, especially regarding cardiovascular conditions, liver or kidney impairment, bleeding disorders, or psychiatric illnesses.
- Avoid alcohol consumption, as it may increase the risk of adverse effects such as dizziness, hypotension, or syncope.
- Use with caution in patients with a history of seizures or mania.
- Not recommended for men with anatomical penile deformities or conditions predisposing to priapism.
- May cause dizziness or blurred vision; refrain from driving or operating machinery until effects are known.
- Regular follow-up with a healthcare provider is advised to monitor therapeutic response and potential side effects.
Contraindications
- Hypersensitivity to Sildenafil Citrate, Dapoxetine, or any excipients in the formulation.
- Concurrent administration with nitrates or nitric oxide donors (e.g., isosorbide mononitrate) due to risk of severe hypotension.
- History of significant cardiovascular disease, including unstable angina, recent myocardial infarction, or life-threatening arrhythmias.
- Severe hepatic impairment (Child-Pugh class C).
- Concomitant use with potent CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) or monoamine oxidase inhibitors (MAOIs).
- Patients with a history of non-arteritic anterior ischemic optic neuropathy (NAION).
Possible side effects
Common side effects may include:
- Headache
- Flushing
- Nasal congestion
- Dizziness
- Nausea
- Diarrhea
- Insomnia
Less frequently reported side effects:
- Visual disturbances (e.g., blurred vision, changes in color perception)
- Tinnitus or hearing loss
- Palpitations
- Orthostatic hypotension
- Increased sweating
- Anxiety or agitation
Rare but serious adverse effects:
- Priapism (prolonged and painful erection)
- Serotonin syndrome (especially with other serotonergic drugs)
- Seizures
- Syncope
- Severe cardiovascular events
Drug interaction
Malegra DXT has several significant drug interactions:
- Nitrates: Absolute contraindication; may cause profound hypotension.
- Alpha-blockers: Increased risk of hypotension; avoid concurrent use.
- Potent CYP3A4 inhibitors: Increase plasma concentrations of Sildenafil; avoid or use with extreme caution.
- Other SSRIs or serotonergic drugs: Risk of serotonin syndrome; avoid combination.
- Antifungal agents (e.g., ketoconazole) and HIV protease inhibitors: May increase Dapoxetine levels.
- Anticoagulants (e.g., warfarin): Potential increased bleeding risk.
- Alcohol: Enhances orthostatic hypotension and dizziness.
Missed dose
Malegra DXT is taken on an as-needed basis; there is no regular dosing schedule. If a dose is missed and sexual activity is anticipated, take one tablet with water as directed, ensuring at least 24 hours have passed since the last dose. Do not double the dose to make up for a missed one.
Overdose
Symptoms of overdose may include severe hypotension, syncope, prolonged erection, serotonin syndrome (agitation, confusion, tachycardia, hyperthermia), or seizures. In case of suspected overdose, seek immediate medical attention. Supportive measures should be instituted, including cardiovascular monitoring and symptomatic treatment. Priapism lasting more than 4 hours requires urgent urological intervention to prevent permanent damage.
Storage
Store at room temperature (15-30°C or 59-86°F) in a dry place, protected from light and moisture. Keep in the original blister pack until use to maintain stability. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Malegra DXT is a prescription medication and should only be used under the supervision of a qualified healthcare provider. Individual results may vary. Always consult with a physician for a proper diagnosis and treatment plan tailored to your specific health needs. Do not initiate or discontinue use without professional guidance.
Reviews
“After struggling with both ED and PE for years, Malegra DXT has been a game-changer. The dual action means I don’t have to worry about timing multiple pills. My confidence has greatly improved.” – Mark T., 52
“As a urologist, I’ve found Malegra DXT to be a reliable option for suitable patients. The combination therapy simplifies treatment and improves adherence, with predictable efficacy when used correctly.” – Dr. A. Reynolds, MD
“I experienced some initial dizziness, but it subsided after the first few uses. The benefits in terms of performance and control have been significant for my relationship.” – James L., 44
“Effective, but requires careful patient selection. Not for everyone, especially those with cardiovascular issues. Always emphasize the need for a thorough pre-treatment evaluation.” – Clinical Pharmacist Review